But then again if youre on another team, youre like, well, this is kind of bullshit, because this guy didnt really win the race
Tirzepatide is an innovative treatment that targets two critical areas: it helps manage Type 2 diabetes by controlling blood sugar levels, and it supports weight loss efforts in patients with obesity or those who are overweight due to medical conditions
The majority of gastrointestinal adverse events occurred during the titration phase of tirzepatide
Heres what the clinical data shows: tirzepatide causes side effects in most people, particularly gastrointestinal issues like nausea, diarrhea, and constipation
And also it is very helpful in conserving the glutathione pool in body cells
Thats when I began to develop the strategy to do a clinical study. Rizzo has been a pioneer in the research and treatment of blinding diseases, with a special focus on optic neuritis and nonarteritic anterior ischemic optic neuropathy (NAION)